FDA Drug Approval, A075795, GLIPIZIDE

FDA Drug Approval, A075795, GLIPIZIDE

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out

Contents: Summary Basis for Approval

ANDA: 075795
Company: APOTEX
Drug Name: GLIPIZIDE
Active Ingredients: GLIPIZIDE
Strength: 10MG
Dosage Form/Route: TABLET;ORAL
Action Date: 06/13/2001
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details